2016 Chateau Haut Beyzac Haut Medoc Cru Bourgeois
Sold Out. Here's What to Buy Instead.
Shop the Best AlternativesOther wines available from Chateau Haut Beyzac →
Set on this exact vintage? Ask us to source it.
We can source just about any wine. 12 bottle minimum quantity required for special orders.
Request a Special OrderAbout The Wine
Château Haut-Beyzac is the last acquisition of the Raguenot Lallez Miller family. They bought the vineyard 1997 and took the time to study the soil and rebuilt the vineyard which naturally benefits from an incredible soil base composed of clay and limestone. 2001 was the first vintage produced and its quality got the attention of renowned wine professionals, press, and earned medals year
after year. Laying the foundation for this impeccable Cru Bourgeois.
Grapes are 100% destemmed. Maceration is done at 30° and lasts for 20 to 30 days. Temperature controlled, malolactic fermentation. The wine is finally aged in neutral oak barrels.
Tasting Notes: Red Wine. 65% Cabernet Sauvignon, 30% Merlot, 5% Petit Verdot. Intense and brilliant red. Fruity nose associated with a toasted wood note. A subtle attack up front, balanced by the smooth tanin structure crescendoed by a round and silky finish. This respectful character of Medoc wines will flatter your palate.
At A Glance
- Varietal:
- Cabernet Sauvignon
- Region:
- Bordeaux
- Size:
- 750ml
CUSTOMER REVIEWS
What Customers Say About This Wine
Related categories
Explore Big Hammer Wines
WINE TYPES
Big Hammer Choice Picks
THE BHW WINE CLUBS
Most people never get access to someone who actually knows wine.
- 5,000+
- wines tasted yearly
- 25 years
- inside the global trade
- 4%
- make the cut
- 1 of 415
- Italian Wine Ambassadors worldwide
Founder Wine Club
- 12 bottles per quarter, personally selected
- Quarterly tasting notes
- Member pricing on all single bottles
- Priority allocation on limited releases
- Access to the BHW member newsletter
President’s Wine Club
- Everything in Founder's Club, plus:
- Private quarterly tasting call with Greg
- Access to pre-release allocations
- Comparable market value exceeding $12,000 annually
